导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.77% | 1821/4773 |
| 近一周 | -2.10% | 1235/5462 |
| 近一月 | -4.19% | 2287/5421 |
| 近一季 | -6.95% | 2248/5209 |
| 近半年 | -1.11% | 1483/4920 |
| 近一年 | 4.17% | 1779/4366 |
| 近两年 | 52.04% | 1420/2954 |
| 近三年 | 19.95% | 1467/2253 |
| 成立以来 | 534.90% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.00% 2618/4961 |
16.16% 1594/5312 |
- - |
- - |
| 2025 | 21.04% 2061/4813 |
-0.60% 2317/3635 |
1.28% 2394/4076 |
19.67% 2113/4524 |
0.46% 1985/4813 |
| 2024 | 4.99% 1855/3463 |
-2.70% 1412/2808 |
-3.80% 1419/3014 |
13.22% 2215/3129 |
-0.93% 1546/3463 |
| 2023 | -14.06% 1580/2656 |
3.42% 1200/2280 |
-7.21% 1811/2385 |
-3.57% 955/2515 |
-7.13% 2064/2655 |
| 2022 | -22.83% 1089/2207 |
-16.79% 1153/1919 |
7.37% 489/2016 |
-13.09% 832/2113 |
-0.61% 1628/2208 |
| 2021 | 5.58% 542/1822 |
-2.59% 673/1255 |
10.33% 476/1330 |
-7.14% 1027/1466 |
5.79% 268/1822 |
| 2020 | 33.88% 446/1250 |
-8.65% 626/1028 |
17.38% 374/1067 |
10.83% 509/1164 |
12.66% 446/1184 |
| 2019 | 39.04% 291/1092 |
29.00% 287/754 |
-1.92% 336/804 |
2.34% 305/850 |
7.38% 441/918 |
| 2018 | -26.87% 405/834 |
- - |
- - |
- - |
-11.90% 376/691 |
| 2017 | 22.94% 142/714 |
- - |
- - |
- - |
- - |
| 2016 | -10.10% 276/605 |
- - |
- - |
- - |
- - |
| 2015 | 10.11% 161/575 |
- - |
- - |
- - |
- - |
| 2014 | 48.99% 92/237 |
- - |
- - |
- - |
- - |
| 2013 | -4.06% 83/186 |
- - |
- - |
- - |
- - |
| 2012 | 8.94% 46/140 |
- - |
- - |
- - |
- - |
| 2011 | -25.63% 75/102 |
- - |
- - |
- - |
- - |
| 2010 | -6.69% 17/58 |
- - |
- - |
- - |
- - |
| 2009 | 85.11% 12/27 |
- - |
- - |
- - |
- - |
| 2008 | -62.46% 13/26 |
- - |
- - |
- - |
- - |
| 2007 | 154.16% 3/22 |
- - |
- - |
- - |
- - |
| 2006 | 121.29% 7/14 |
- - |
- - |
- - |
- - |
| 2005 | -0.56% 3/11 |
- - |
- - |
- - |
- - |
| 2004 | -9.02% 1/4 |
- - |
- - |
- - |
- - |
| 2003 | 11.42% 1/1 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 华安中国A股增强指数 VS. 长安沪深300非周期A(740101) |